Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy
Launched by OHSU KNIGHT CANCER INSTITUTE · Feb 18, 2020
Trial Information
Current as of May 29, 2025
Terminated
Keywords
ClinConnect Summary
PRIMARY OBJECTIVE:
I. To assess if proximal knowledge regarding radiation therapy (RT) treatment is improved as result of radiation therapist-led education sessions utilizing VERT.
SECONDARY OBJECTIVE:
I. To assess if proximal anxiety related to first RT is reduced as result of radiation therapist-led education sessions utilizing VERT.
EXPLORATORY OBJECTIVES:
I. To determine whether self-reported knowledge changes throughout course of RT treatment.
II. To evaluate if self-reported knowledge related to RT treatment differs by patient and tumor characteristics (gender, age, diagnosis, t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to understand and the willingness to sign a written informed consent document
- • All races and ethnic groups will be included
- • Participants with any cancer diagnosis that is intended to receive RT for curative intent for their cancer
- • Participants must have a minimum of 10 planned RT treatments
- Exclusion Criteria:
- • Any prior RT
- • Known history of anxiety or depression
- • Individuals with known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- • Any condition that, in the opinion of the investigator, would interfere with evaluation of study treatment or interpretation of participant safety or study results
- • Inability to understand either English or Spanish
About Ohsu Knight Cancer Institute
The OHSU Knight Cancer Institute is a leading research and treatment center dedicated to advancing cancer care through innovative clinical trials and groundbreaking research. Part of Oregon Health & Science University, the institute is recognized for its multidisciplinary approach, combining expertise in oncology, genomics, and patient care to develop novel therapies and improve treatment outcomes. With a commitment to translating scientific discoveries into clinical applications, the OHSU Knight Cancer Institute strives to enhance the quality of life for cancer patients while fostering collaboration among researchers, clinicians, and the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Portland, Oregon, United States
Patients applied
Trial Officials
Kristi Tonning
Principal Investigator
OHSU Knight Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials